• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis

tetano

Editor, Senior Moderator
Proc Natl Acad Sci U S A. 2017 Jul 10. pii: 201620415. doi: 10.1073/pnas.1620415114. [Epub ahead of print]
[h=1]Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.[/h] Blackmore S[SUP]1[/SUP], Hernandez J[SUP]1[/SUP], Juda M[SUP]1[/SUP], Ryder E[SUP]2[/SUP], Freund GG[SUP]1,[/SUP][SUP]3[/SUP], Johnson RW[SUP]1,[/SUP][SUP]2,[/SUP][SUP]4[/SUP], Steelman AJ[SUP]5,[/SUP][SUP]2,[/SUP][SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Multiple sclerosis (MS) is an autoimmune disease of the central nervous system. Most MS patients experience periods of symptom exacerbation (relapses) followed by periods of partial recovery (remission). Interestingly, upper-respiratory viral infections increase the risk for relapse. Here, we used an autoimmune-prone T-cell receptor transgenic mouse (2D2) and a mouse-adapted human influenza virus to test the hypothesis that upper-respiratory viral infection can cause glial activation, promote immune cell trafficking to the CNS, and trigger disease. Specifically, we inoculated 2D2 mice with influenza A virus (Puerto Rico/8/34; PR8) and then monitored them for symptoms of inflammatory demyelination. Clinical and histological experimental autoimmune encephalomyelitis was observed in ∼29% of infected 2D2 mice. To further understand how peripheral infection could contribute to disease onset, we inoculated wild-type C57BL/6 mice and measured transcriptomic alterations occurring in the cerebellum and spinal cord and monitored immune cell surveillance of the CNS by flow cytometry. Infection caused temporal alterations in the transcriptome of both the cerebellum and spinal cord that was consistent with glial activation and increased T-cell, monocyte, and neutrophil trafficking to the brain at day 8 post infection. Finally, Cxcl5 expression was up-regulated in the brains of influenza-infected mice and was elevated in cerebrospinal fluid of MS patients during relapse compared with specimens acquired during remission. Collectively, these data identify a mechanism by which peripheral infection may exacerbate MS as well as other neurological diseases.


[h=4]KEYWORDS:[/h] experimental autoimmune encephalomyelitis; immune cell surveillance; multiple sclerosis; neuroinflammation; upper-respiratory viral infection

PMID: 28696309 DOI: 10.1073/pnas.1620415114
 
Back
Top Bottom